ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Renal failure"

  • 2016 American Transplant Congress

    Prolonged Pre-Transplant Dialysis Duration Reverses the “Nephroprotective Effect” in Simultaneous Liver-Kidney Transplant Recipients.

    M. Casey, X. Wen, A. Santos, S. Rehman, K. Womer.

    University of Florida, Gainesville.

    Past literature has suggested that simultaneous liver-kidney(SLK) transplant recipients may experience a nephroprotective effect compared to kidney(Ki) alone transplant recipients. Since hepatorenal syndrome is a…
  • 2016 American Transplant Congress

    The Impact of Kidney Donor Profile Index (KDPI) on Rates of Delayed Graft Function (DGF).

    T. Zens, G. Leverson, R. Redfield, P. Chlebeck, L. Zitur, D. Kaufman, L. Fernandez.

    Surgery, University of Wisconsin, Madison, WI.

    Introduction: Delayed graft function (DGF) is the need for dialysis within the first 7 days after kidney transplantation. Immunologic and non-immunologic donor and recipient factors…
  • 2016 American Transplant Congress

    Hyponatremia in Early Post Lung Transplantation Predicts Patient and Hospital Outcomes.

    E. Tantisattamo,1 A. Chokechanachaisakul,2 O. Traitanon,3 A. Shetty,2 B. Ho,2 J. Friedewald,2 S. Bhorade,2 A. Haynes,2 A. Nieland,2 L. Gallon.2

    1Oakland University William Beaumont School of Medicine, Royal Oak, MI; 2Northwestern University Feinberg School of Medicine, Chicago, IL; 3Department of Medicine-Nephrology, Thammasart University Hospital, Pathumthani, Thailand.

    Background: Outcomes of hyponatremia during immediate post-lung transplantation are unknown. We aim to identify the incidence of postoperative hyponatremia and its outcomes.Methods: All lung transplantations…
  • 2016 American Transplant Congress

    Pre-Emptive Kidney Transplantation with Living- Donor and Concomitant Unilateral Nephrectomy in Patients with Autosomal-Dominant Polycystic Kidney Disease: A Safe Strategy?

    C. Michel,1 F. Audenet,1 M. Ariane,1 C. Legendre,2 D. Joly,2 A. Méjean,1 M.-O. Timsit.1

    1Urology, Hôpital Européen Georges Pompidou, Paris, France; 2Nephrology and Transplantation, Hôpital Necker, Paris, France.

    Objectives. Because the timing of the nephrectomy still remains unclear, we studied the complications and outcomes of unilateral nephrectomy and concomitant pre-emptive kidney transplant with…
  • 2016 American Transplant Congress

    Parameters of Uremia-Associated Premature Ageing of Peripheral T Cells Do Not Predict Infectious Complications After Renal Transplantation.

    B. Dedeoglu, R. Meijers, M. Klepper, D. Hesselink, C. Baan, N. Litjens, M. Betjes.

    Internal Medicine, Nephrology and Transplantation, Erasmus MC, University Medical Centre, Rotterdam, Netherlands.

    Background: End-stage renal disease (ESRD) patients have a prematurely aged T-cell system, which may contribute to the uremia-associated immune deficiency. In this study we tested…
  • 2016 American Transplant Congress

    Kidney Transplantation with Strong Preformed Donor-Specific Antibodies: Impact of C1q-Binding Ability.

    J. Malheiro,1 S. Tafulo,2 S. Santos,1 M. Costa,1 L. Martins,1 L. Dias,1 A. Henriques.1

    1Nephrology, CHP, Porto, Portugal; 2CSTP, Porto, Portugal.

    HLA-incompatible kidney transplantation is associated with worse outcomes given the presence of donor-specific anti-HLA antibodies (DSA). Our aim was to investigate the association between preformed…
  • 2016 American Transplant Congress

    Kidney Transplants from Anuric Deceased Donors on Renal Replacement Therapy.

    W. Bry, J. Bellingham, S. Katznelson, P. Patel, K. Ueda, H. Mahanty, N. Neidlinger, A. Hassoun, V. Peddi.

    Transplantation, California Pacific Medical Center, San Francisco, CA.

    Transplantation of deceased donor kidneys with Acute Kidney Injury (AKI) has become a generally well accepted practice with excellent results documented in the literature. The…
  • 2016 American Transplant Congress

    Geographic Variability in Access to Transplant Centers for Children with End-Stage Renal Disease.

    C. Toro,1 M. Ross,1,2 D. Wiebe,2 S. Amaral.1,2

    1Pediatrics, The Children's Hospital of Phila, Philadelphia, PA; 2Biostatistics and Epidemiology, The University of Pennsylvania, Philadelphia, PA.

    Background: Kidney transplantation is the optimal treatment for pediatric end-stage renal disease (ESRD); yet, there is substantial variability in waiting times for deceased donor kidneys…
  • 2016 American Transplant Congress

    Acute Kidney Injury (AKI) Associated with Chronic Kidney Disease (CKD) in Paediatric Non-Kidney Transplant Recipients.

    C. Williams,1,2 K. Borges,2 T. Banh,2 J. Vasilevska-Ristovska,2 R. Chanchlani,1,2 V. Ng,1,2 A. Dipchand,1,2 M. Solomon,1,2 D. Hebert,1,2 S. Kim,1,3 B. Astor,4 R. Parekh.1,2,3

    1University of Toronto, Toronto, Canada; 2Hospital for Sick Children, Toronto, Canada; 3University Health Network, Toronto, Canada; 4University of Wisconsin, Madison.

    Background: Kidney dysfunction is common after solid organ transplantation; however, rates of post-transplant AKI and CKD in children are unknown.Objective: Determine rates of AKI and…
  • 2016 American Transplant Congress

    Renal Outcome with Eculizumab in Patients with aHUS with Native and Transplanted Kidneys: Pooled Analysis of 100 Patients.

    C. Legendre,1 J. Campistol,2 T. Feldkamp,3 J. Wang,4 G. Remuzzi,5 L. Weekers,6 N. Sheerin.7

    1Université Paris Descartes & Hôpital Necker, Paris, France; 2Hospital Clinic, University of Barcelona, Barcelona, Spain; 3University Hospital Schleswig-Holstein, Kiel, Germany; 4Alexion Pharmaceuticals, Inc., Cheshire, CT; 5IRCCS-Istituto di Ricerche Farmacologiche Mario Negri, Bergamo, Italy; 6CHU de Liège, Liège, Belgium; 7Newcastle University, Newcastle upon Tyne, United Kingdom.

    Purpose: aHUS often progresses to ESRD and requires transplant (tx). Eculiumab (ECU), a terminal complement inhibitor, inhibits TMA irrespective of tx status. We evaluated outcomes…
  • « Previous Page
  • 1
  • …
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences